GlycoMimetics(GLYC) - 2025 Q1 - Quarterly Results

Exhibit 99.2 CRESCENT BIOPHARMA, INC. CONDENSED BALANCE SHEETS (UNAUDITED) (in thousands except share and per share amounts) | | March 31, | | | December 31, | | --- | --- | --- | --- | --- | | | | 2025 | | 2024 | | Assets | | | | | | Current assets: | | | | | | Cash | $ | 22,429 | $ | 34,766 | | Prepaid expenses and other current assets | | 409 | | 38 | | Total current assets | | 22,838 | | 34,804 | | Other assets | | 2,767 | | 813 | | Total assets | $ | 25,605 | $ | 35,617 | | Liabilities, Convertible Pre ...